DexCom, Inc. (DXCM)
85.96
+1.85
(+2.20%)
USD |
NASDAQ |
Oct 12, 11:15
DexCom Free Cash Flow (Quarterly) : 184.50M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 184.50M |
| March 31, 2026 | 449.00M |
| December 31, 2025 | 192.10M |
| September 30, 2025 | 579.40M |
| June 30, 2025 | 208.90M |
| March 31, 2025 | 96.80M |
| December 31, 2024 | 176.80M |
| September 30, 2024 | 88.30M |
| June 30, 2024 | 213.30M |
| March 31, 2024 | 152.30M |
| December 31, 2023 | 81.10M |
| September 30, 2023 | 218.80M |
| June 30, 2023 | 131.30M |
| March 31, 2023 | 80.70M |
| December 31, 2022 | 69.00M |
| September 30, 2022 | 185.00M |
| June 30, 2022 | 81.30M |
| March 31, 2022 | -30.60M |
| December 31, 2021 | 25.60M |
| September 30, 2021 | 139.20M |
| June 30, 2021 | -39.60M |
| March 31, 2021 | -71.90M |
| December 31, 2020 | 111.80M |
| September 30, 2020 | 100.20M |
| June 30, 2020 | 95.90M |
| Date | Value |
|---|---|
| March 31, 2020 | -31.30M |
| December 31, 2019 | 99.60M |
| September 30, 2019 | 44.80M |
| June 30, 2019 | 17.60M |
| March 31, 2019 | -27.50M |
| December 31, 2018 | 16.00M |
| September 30, 2018 | 33.00M |
| June 30, 2018 | 31.10M |
| March 31, 2018 | -24.00M |
| December 31, 2017 | 23.60M |
| September 30, 2017 | 22.70M |
| June 30, 2017 | 2.30M |
| March 31, 2017 | -22.60M |
| December 31, 2016 | -4.30M |
| September 30, 2016 | 6.90M |
| June 30, 2016 | 9.60M |
| March 31, 2016 | -11.70M |
| December 31, 2015 | -0.30M |
| September 30, 2015 | 9.80M |
| June 30, 2015 | 9.80M |
| March 31, 2015 | -4.60M |
| December 31, 2014 | 3.80M |
| September 30, 2014 | 7.70M |
| June 30, 2014 | 2.20M |
| March 31, 2014 | -6.30M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Abbott Laboratories | 1.991B |
| Baxter International, Inc. | 166.00M |
| Insulet Corp. | 51.20M |
| Stryker Corp. | 1.059B |
| Becton, Dickinson & Co. | 509.00M |